ADAR1 Capital Management »

Mitek Systems shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Mitek Systems (MITK) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Mitek Systems

Tip: Access up to 7 years of quarterly data

All positions including Mitek Systems held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mitek Systems by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $79k 5.6k 14.10
2023-12-31 $99k 7.6k 13.04

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Mitek Systems

BlackRock
BlackRock
Vanguard Group
Blue Grotto Capital
Independent Advisor Alliance
Dimensional Fund Advisors
Toronado Partners
State Street Corporation
Geode Capital Management
Newtyn Management
Ranger Investment Management
Thompson, Siegel, & Walmsley
Portolan Capital Management
Kent Lake PR
Silvercrest Asset Management Group

View all funds holding Mitek Systems